(Q40590761)
Statements
Rituximab (Mabthera, Rituxan) in patients with recurrent indolent lymphoma: evaluation of safety and efficacy in a multicenter study (English)
A Dmoszyńska
J Hołowiecki
S Grosicki
A Hellmann
J Czyz
M Komarnicki
K Kuliczkowski
J Dwilewicz-Trojaczek
T Robak
Polish Lymphoma Research Group
E Kraszewska
O Mioduszewska
J Romejko-Jarosińska
M Kopera
L Rumianowski
J Załuski
A Walter-Croneck
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference